Interactions of agonists with an allosteric antagonist at muscarinic acetylcholine M2 receptors

European Journal of Pharmacology

Volumn 316, Issue 1, 1996, Pages 27-32

  Lanzafame, Alfred ^a   Christopoulos, Arthur ^a   Mitchelson, Fred ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Bisquaternary allosteric antagonist; Muscarinic acetylcholine receptor agonist

Indexed keywords

1,3 DIOXOLANE; ACETYLCHOLINE; CARBACHOL; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OXOTREMORINE;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; FEMALE; GUINEA PIG; HEART LEFT ATRIUM; MALE; NONHUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ACETYLCHOLINE; ANIMALS; BINDING, COMPETITIVE; BIS-TRIMETHYLAMMONIUM COMPOUNDS; BUFFERS; CARBACHOL; DIOXOLANES; DRUG INTERACTIONS; FEMALE; GUINEA PIGS; KINETICS; MALE; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; OXOTREMORINE; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC;

EID: 0030605219     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00639-5     Document Type: Article

References (17)

1. Ariëns, E.J., J.M. Van Rossum and A.M. Simonis, 1956, A theoretical basis of molecular pharmacology, Arzneim. Forsch. 6, 611.
2. Arunlakshana, O. and H.O. Schild, 1959, Some quantitative uses of drug antagonists, Br. J. Pharmacol. Chemother. 14, 48.
3. 2-receptors, Naunyn-Schmiedeberg's. Arch. Pharmacol. 353, R83.
4. Christopoulos, A. and F. Mitchelson, 1994, Assessment of the allosteric interaction of the bisquaternary heptane-1,7-bis(dimethyl-3′-phthalimidopropyl ammonium bromide), at M1 and M2 muscarine receptors, Mol. Pharmacol. 46, 105.
5. 3H]N-methylscopolamine dissociation from muscarinic receptors affected by low concentrations of allosteric modulators. Eur. J. Pharmacol. (Mol. Pharmacol. Sect.) 290, 259.
6. Clark, A.L. and F. Mitchelson, 1976, The inhibitory effects of gallamine on muscarinic receptors, Br. J. Pharmacol. 58, 323.
7. + channels by gallamine and a novel bisquaternary quinolinium cyclophane, UCL 1530, Br. J. Pharmacol. 117, 35.
8. Ehlert, F.J., 1988, Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods, Mol. Pharmacol. 33, 187.
9. Freeman, S.E. and R.M. Dawson, 1991, Tacrine: a pharmacological review, Prog. Neurobiol. 36, 257.
10. Jepsen, K., H. Lüllmann, K. Mohr and J. Pfeffer, 1989, Allosteric alterations of muscarinic receptors, Prog. Pharmacol. Clin. Pharmacol. 7, 41.
11. Lee, N.H. and E.E. EI-Fakahany, 1988, Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions, J. Pharmacol. Exp. Ther. 246, 829.
12. Lee, N.H. and E.E. El-Fakahany, 1991, Allosteric antagonists of the muscarinic acetylcholine receptor, Biochem. Pharmacol. 42, 199.
13. Lüllmann, H., F.K. Ohnesorge, G.C. Schauwecker and O. Wassermann, 1969, Inhibition of the actions of carbachol and DFP on guinea pig isolated left atria by alkane bis-ammonium compounds, Eur. J. Pharmacol. 6, 241.
14. Miller, R.G., 1966, Simultaneous Statistical Inference (McGraw Hill, New York, NY).
15. Mitchelson, F., 1975, Antimuscarinic action of an alkane-bis-ammonium compound alone and in combination with (+)-benzetimide, Eur. J. Pharmacol. 33, 237.
16. Stockton, J.M., N.J.M. Birdsall, A.S.V. Burgen and E.C. Hulme, 1983, Modification of the binding properties of muscarinic receptors by gallamine, Mol. Pharmacol. 23, 551.
17. Van den Brink, F.G., 1977, General theory of drug-receptor interactions, in: Handbuch der experimentellen Pharmakologie, Vol. 47, Kinetics of Drug Action, ed. J.M. Van Rossum (Springer, Berlin) p. 169.